Speaking at the launch of the CiplaQCiL initial public offering, Paul Bwiso, CEO USE termed the decison for the pharmaceutical giant to open up to the public as remarkable. CiplaQCiL came to the market at UGX.256.5 offer price per offer share. A price that created a fun fact labelling the IPO as the Country Coded IPO.
To read more on this, view the attachment below. Please read the prospectus.
Patience does pays. The shareholders of the EABL counter on the Uganda Securities Exchange will be reaping big with a sh276 dividend per share. "Our goal as a company is to ensure that we continue to satisfy our consumer hence innovation being at the centre of our success..." Mark Ociti Ongom CEO EABL.
For more details view attachment below;